会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Composition for Prevention or Treatment of Hyperlipidemia, Fatty Liver or Obesity
    • 预防或治疗高脂血症,脂肪肝或肥胖的组合物
    • US20110135717A1
    • 2011-06-09
    • US13056805
    • 2009-07-31
    • Seung Woo Kang
    • Seung Woo Kang
    • A61K31/715A61K9/127A61P3/06A61P9/00A61P3/04
    • A61K31/715A23L33/10A23V2002/00A61K31/7016A61K31/702C07H3/06A23V2200/326A23V2200/332A23V2250/5438
    • Disclosed is a composition for prophylaxis or treatment of hyperlipidemia, fatty liver, cardiovascular disease or obesity including a compound represented by General Formula I as an effective ingredient: S- (MS)p-(MS)q  General Formula I wherein S represents sialic acid, and (MS)p and (MS)q independently represent a monosaccharide residue.The compound used as the effective ingredient induces body weight loss, decrease of organ fat, decrease of total cholesterol level, increase of HDL-cholesterol level, decrease of LDL-cholesterol level and decrease of leptin, and thereby provides prophylactic or therapeutic activity for hyperlipidemia, fatty liver, cardiovascular disease or obesity. Also, because it has no cytotoxicity or skin side effect, the provided composition may be safely used as a pharmaceutical composition, a neutraceutical composition or a food composition.
    • 公开了用于预防或治疗高脂血症,脂肪肝,心血管疾病或肥胖的组合物,其包括通式I所示的化合物作为有效成分:S-(MS)对 - (MS)q通式I其中S表示唾液酸 ,(MS)p和(MS)q独立地表示单糖残基。 用作有效成分的化合物诱导体重减轻,器官脂肪减少,总胆固醇水平降低,HDL-胆固醇水平升高,LDL-胆固醇水平降低和瘦素降低,从而为高脂血症提供预防或治疗活性 ,脂肪肝,心血管疾病或肥胖。 此外,由于其没有细胞毒性或皮肤副作用,所提供的组合物可以安全地用作药物组合物,营养成分或食品组合物。
    • 4. 发明申请
    • AIR CONDITIONER AND METHOD OF CONTROLLING THE SAME
    • 空调器及其控制方法
    • US20070266719A1
    • 2007-11-22
    • US11750245
    • 2007-05-17
    • Seung Woo KANGJi Young JANGChan Ho SONGSeung Youp HYUN
    • Seung Woo KANGJi Young JANGChan Ho SONGSeung Youp HYUN
    • F25B39/04F25B49/00
    • F25B49/022F24F11/30F24F2110/00F25B2400/075F25B2500/26F25B2600/01F25B2600/021F25B2600/111F25B2600/2513Y02B30/741Y02B30/743
    • An air conditioner includes first and second compressors, an outdoor heat exchanger through which refrigerant discharged from the first and second compressors passes, an outdoor fan for forcedly directing air toward the outdoor heat exchanger, an expansion valve for expanding the refrigerant discharged from the outdoor heat exchanger, an indoor heat exchanger through which the refrigerant expanded in the expansion valve passes, a linear expansion valve for adjust a flow rate of the refrigerant, a load detecting unit for deterring an indoor load, and a control unit for controlling the operation of the first and second compressors in accordance with the detected indoor load. In a state where the second compressor is not driven, the control unit allows the second compressor to drive when a driving start conditioner of the second compressor is satisfied and a driving start retarding time has been elapsed. The control unit adjusts an opening of the linear expansion valve and an operation of the outdoor fan for the driving start retarding time.
    • 空调机包括第一和第二压缩机,从第一和第二压缩机排出的制冷剂通过的室外热交换器,用于将空气强制地引向室外热交换器的室外风扇,用于使从室外热排出的制冷剂膨胀的膨胀阀 交换器,膨胀阀膨胀的制冷剂通过的室内热交换器,用于调节制冷剂的流量的线性膨胀阀,用于阻止室内负载的负载检测单元,以及用于控制制冷剂的运转的控制单元 第一和第二压缩机根据检测到的室内负载。 在第二压缩机不被驱动的状态下,当满足第二压缩机的驾驶起动调节器并且已经经过了驾驶开始延迟时间时,控制单元允许第二压缩机驱动。 控制单元调节线性膨胀阀的开度和用于驾驶开始延迟时间的室外风扇的操作。
    • 8. 发明授权
    • Composition for prevention or treatment of eye diseases
    • 预防或治疗眼睛疾病的组合物
    • US08524686B2
    • 2013-09-03
    • US13124965
    • 2009-10-16
    • Seung Woo KangCheorl-Ho KimSeok-Jo Kim
    • Seung Woo KangCheorl-Ho KimSeok-Jo Kim
    • A61K31/70
    • A61K31/7016A23L33/10A23V2002/00C11D3/0078C11D3/221C11D3/227A23V2200/30
    • Provided is a composition for prophylaxis or treatment of an eye disease comprising a compound represented by General Formula I: S-(MS)p-(MS)q  General Formula I wherein S represents sialic acid, and (MS)p and (MS)q independently represent a monosaccharide residue. The compound used as the active ingredient inhibits expression of MMP-9 and inflammation-mediated cytokines (IL-1β, TNF-α, etc.) in corneal epithelial cells and inhibits VEGF-mediated VEGFR-2 activation in human retinal endothelial cells (HREC), thereby exhibiting prophylactic or therapeutic activity for eye diseases such as dry eye syndrome, inflammatory eye disease, neovascularization-associated eye disease and side effects of wearing of contact lenses. Also, because it has no cytotoxicity or skin side effect, the provided composition may be safely used as a pharmaceutical composition, a neutraceutical composition or a food composition. In addition, the composition may be used as a cleaner or a lubricant for contact lenses since it has nonbacterial antiinflammatory activity and ocular contact lubricating activity.
    • 本发明提供一种预防或治疗眼病的组合物,其包含通式I表示的化合物:S-(MS)对 - (MS)q通式I其中S表示唾液酸,(MS)p和(MS)q 独立地表示单糖残基。 用作活性成分的化合物抑制角膜上皮细胞中MMP-9和炎症介导的细胞因子(IL-1β,TNF-α等)的表达,并抑制人视网膜内皮细胞(HREC)中VEGF介导的VEGFR-2活化 ),从而对眼病,如干眼综合征,炎症性眼病,新血管形成相关眼病以及隐形眼镜的佩戴副作用表现出预防或治疗活性。 此外,由于其没有细胞毒性或皮肤副作用,所提供的组合物可以安全地用作药物组合物,营养成分或食品组合物。 此外,该组合物可用作隐形眼镜的清洁剂或润滑剂,因为它具有非细菌抗炎活性和眼部接触润滑活性。
    • 9. 发明申请
    • Composition for Prevention or Treatment of Eye Diseases
    • 预防或治疗眼部疾病的组合物
    • US20110237543A1
    • 2011-09-29
    • US13124965
    • 2009-10-16
    • Seung Woo KangCheorl-Ho KimSeok-Jo Kim
    • Seung Woo KangCheorl-Ho KimSeok-Jo Kim
    • A61K31/702A61P27/02A61P27/04A61P37/06A61P35/00A61P29/00
    • A61K31/7016A23L33/10A23V2002/00C11D3/0078C11D3/221C11D3/227A23V2200/30
    • Provided is a composition for prophylaxis or treatment of an eye disease comprising a compound represented by General Formula I: S-(MS)p-(MS)q  General Formula I wherein S represents sialic acid, and (MS)p and (MS)q independently represent a monosaccharide residue. The compound used as the active ingredient inhibits expression of MMP-9 and inflammation-mediated cytokines (IL-1β, TNF-α, etc.) in corneal epithelial cells and inhibits VEGF-mediated VEGFR-2 activation in human retinal endothelial cells (HREC), thereby exhibiting prophylactic or therapeutic activity for eye diseases such as dry eye syndrome, inflammatory eye disease, neovascularization-associated eye disease and side effects of wearing of contact lenses. Also, because it has no cytotoxicity or skin side effect, the provided composition may be safely used as a pharmaceutical composition, a neutraceutical composition or a food composition. In addition, the composition may be used as a cleaner or a lubricant for contact lenses since it has nonbacterial antiinflammatory activity and ocular contact lubricating activity.
    • 本发明提供用于预防或治疗眼病的组合物,其包含通式I表示的化合物:S-(MS)对 - (MS)q通式I其中S表示唾液酸,(MS)p和(MS) q独立地表示单糖残基。 用作活性成分的化合物抑制角膜上皮细胞中MMP-9和炎症介导的细胞因子(IL-1和bgr,TNF-α等)的表达,并抑制人视网膜内皮细胞中VEGF介导的VEGFR-2活化( HREC),从而表现出眼病,如干眼综合征,炎症性眼病,新生血管相关性眼病以及隐形眼镜佩戴的副作用的预防或治疗活性。 此外,由于其没有细胞毒性或皮肤副作用,所提供的组合物可以安全地用作药物组合物,营养成分或食品组合物。 此外,该组合物可用作隐形眼镜的清洁剂或润滑剂,因为它具有非细菌抗炎活性和眼部接触润滑活性。
    • 10. 发明授权
    • Processing method of data stream using border monitoring query
    • 使用边界监控查询的数据流处理方法
    • US07895188B2
    • 2011-02-22
    • US11741923
    • 2007-04-30
    • Jin Won LeeYoung Ki LeeSeung Woo KangSang Jeong LeeHyun Ju JinByung Jip KimJune Hwa Song
    • Jin Won LeeYoung Ki LeeSeung Woo KangSang Jeong LeeHyun Ju JinByung Jip KimJune Hwa Song
    • G06F7/00G06F17/30
    • G06F17/30675
    • The present invention relates to a processing method of data stream using Border Monitoring Query, and more particularly a monitoring method and a system for data streams which are a large volume of data and continuously generated such as financial ticker, GPS data or a ubiquitous sensor network (USN).The objectives of the present invention are to process a large number of BMQs over data streams in high-performance and scalable manner. For this purpose, the invention presents BMQ-Index, a scalable and high performance data stream monitoring framework. The main idea of BMQ-Index is shared and incremental processing. For shared processing, BMQ-Index adopts a query indexing approach, thereby achieving a high level of scalability. Once BMQ-Index is built on registered queries, only relevant queries are quickly searched for upon an incoming data. For incremental processing, BMQ-Index employs an incremental access method, i.e., an index structure to store delta query information and an incremental search algorithm. Thus, successive BMQ evaluations are greatly accelerated.
    • 本发明涉及使用边界监视查询的数据流的处理方法,更具体地说,涉及一种数据流的监视方法和系统,该数据流是大量的数据并连续生成的,例如金融报价单,GPS数据或普遍存在的传感器网络 (USN)。 本发明的目标是以高性能和可扩展的方式处理数据流上的大量BMQ。 为此,本发明提出了可扩展和高性能的数据流监测框架BMQ-Index。 BMQ-Index的主要思想是共享和增量处理。 对于共享处理,BMQ-Index采用查询索引方式,从而实现了高度的可扩展性。 一旦BMQ-Index建立在注册查询上,只有在输入数据时快速搜索相关查询。 对于增量处理,BMQ-Index使用增量访问方法,即用于存储增量查询信息和增量搜索算法的索引结构。 因此,连续的BMQ评估大大加快。